sameAs
Genome sequence of erythromelalgia-related poxvirus identifies it as an ectromelia virus strainCloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cellsReverse genetics analysis of poxvirus intermediate transcription factorsAmino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicinOrigin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factorsSimian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251...Poxvirus membrane biogenesisPoxvirus cell entry: how many proteins does it take?Overcoming immunity to a viral vaccine by DNA priming before vector boostingVaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimerPoxvirus DNA replicationDrosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcriptionVaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesinPrevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccineVaccinia virus L2 protein associates with the endoplasmic reticulum near the growing edge of crescent precursors of immature virions and stabilizes a subset of viral membrane proteinsDiscovery of antivirals against smallpoxDifferent patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses.Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions.Formation of orthopoxvirus cytoplasmic A-type inclusion bodies and embedding of virions are dynamic processes requiring microtubules.Salmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae.Viruses know more than one way to don a capImmunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Kinetics and intracellular location of intramolecular disulfide bond formation mediated by the cytoplasmic redox system encoded by vaccinia virus.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceRole of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particlesVaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusionSignature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateCellular DNA ligase I is recruited to cytoplasmic vaccinia virus factories and masks the role of the vaccinia ligase in viral DNA replication.Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsEpitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesEffects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly.Vaccinia virus A21 virion membrane protein is required for cell entry and fusionThe product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing
P50
Q21134699-E86432B9-3A12-4948-B001-45CE7B21D893Q24535851-01211798-0E9D-408D-8CC8-21D23EF7244BQ24620092-4B035870-BAEC-4FFB-A8D7-E8D0B85473D5Q24682102-97B80C07-A0A4-40C2-8B72-95B313A9A089Q24796835-3DA4F00B-8D84-40CF-A39F-8ECBBE50D4BAQ24798276-4C56BFB3-0ECD-4E61-8B5C-50B02ECB3C4AQ26823774-EE74EA12-A93D-448F-99F0-6CF8A70D3E83Q27002455-B210A81C-0592-4C8A-AF80-F1A70FDB6EEBQ28217213-09947D4A-EAA6-4193-A6CA-4E3FDF3C8F39Q28286795-0BE6490D-25E4-4F02-A5C4-5D1495A062B4Q28294254-C0F747DE-BCB3-4EC5-8F2E-58078598C932Q28477161-AFC2144A-8CB8-42E4-8B6E-FE59A3A3076DQ28576187-E67B0939-E16F-4BF2-B07B-42980848907EQ28742137-70F8FE80-AC22-4D89-B0D4-9344E7026F6CQ28743094-87A374BB-31A8-43F4-B7CE-F6A0A1F5828EQ28770151-DD3004F4-054F-4871-B131-1C7C4405FA5CQ30330620-F6D6EDF7-781B-4A17-A706-5F5D8803F70CQ30350247-939470A4-C81F-4A06-92BB-8241C9E90F90Q30374995-7B3E5730-835E-4284-B70C-299204395A3BQ30480693-91BA43E1-3BFE-4DD5-9F9A-204B3AD76B97Q30513986-580DBBF8-55F3-43F6-9886-F49558708F8DQ30978284-42C0A98D-86CE-405C-A24E-5158B199F5E2Q33532353-5E20B9CD-7448-4E5E-9885-C483ECD877C5Q33653655-2B0B62DC-E971-466C-ABCF-15F2B9597482Q33664851-CBDCAF80-A44E-48BA-99FF-0255DC6B4449Q33696283-4B2AD2BA-2601-4ECE-9D2E-90FDBF9A7324Q33707339-A03EB7DA-05BF-4492-8EAA-0333558C4532Q33724218-6834BE09-A7DC-4F3F-884C-9A2FE258C363Q33737811-1D74AA0B-F054-4140-B58D-CD1BBFC3F52EQ33749950-79AE507A-0BE9-470A-BDA8-533A13B38275Q33757344-647C2BC4-71F9-4BA0-AB25-FDF44B8AF766Q33770634-C71B5D62-2C95-43E7-8BA6-4205801E81C8Q33780553-2C3D83AD-26A7-4B12-B3B9-C5B765EB8840Q33788819-5ABCA79E-2A11-4673-84BD-D22CDE22CBBDQ33813145-35AECD59-60F0-4EF4-BCCB-34977EEFB6BCQ33843383-22D8ED40-65C3-4F60-B430-27A29493BC5DQ33908798-850631CC-1E58-4DF1-969F-0E0BE1862299Q33930439-9AD19DFC-79CB-4F15-B95A-C5B74A068588Q33934294-BB2E2799-C494-414E-89AF-F441E84C162AQ33953053-763DE46A-1587-4CB7-BA71-A601EB41E532
P50
description
Virologe, Biochemiker und Molekularbiologe
@de
moleculair bioloog
@nl
virologist
@en
name
Bernard Moss
@ast
Bernard Moss
@de
Bernard Moss
@en
Bernard Moss
@es
Bernard Moss
@fr
Bernard Moss
@it
Bernard Moss
@nl
Bernard Moss
@sl
برنارد موس
@ar
type
label
Bernard Moss
@ast
Bernard Moss
@de
Bernard Moss
@en
Bernard Moss
@es
Bernard Moss
@fr
Bernard Moss
@it
Bernard Moss
@nl
Bernard Moss
@sl
برنارد موس
@ar
altLabel
B Moss
@en
B. Moss
@en
Moss B
@en
Moss B.
@en
Moss
@en
Moss-B
@en
prefLabel
Bernard Moss
@ast
Bernard Moss
@de
Bernard Moss
@en
Bernard Moss
@es
Bernard Moss
@fr
Bernard Moss
@it
Bernard Moss
@nl
Bernard Moss
@sl
برنارد موس
@ar
P106
P166
P214
P2163
P227
P244
P166
P21
P214
P2163
P227
1207787892
P244
P31
P3835
bernard-moss
P496
0000-0002-2154-8564
P5380
P569
1937-07-26T00:00:00Z
P734
P735
P7859
lccn-n93804035